Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Expand chart
Data: Company filings; Chart: Sara Wise/Axios

The four main drug companies making COVID-19 vaccines have sold a combined $18.6 billion worth of the shots in the first half of 2021, and sales are expected to reach a combined $60 billion by the end of the year.

The big picture: Even though the U.S. represents less than 5% of the global population, the U.S. market makes up 41% of the vaccine sales.

Between the lines: Vaccine makers have sent more vaccines and charged higher prices to wealthy countries, including the U.S. The higher prices are part of the reason Pfizer and Moderna have advocated for booster shots even though their vaccines remain very effective after six months and against the Delta variant.

  • The World Health Organization has called for a moratorium on boosters so more unvaccinated people in low-income countries can get their first shots.

By the numbers: Pfizer and Moderna have collected more than 90% of global COVID-19 vaccine revenues.

  • Pfizer alone accounts for 60% of worldwide sales. Moderna's two-dose vaccine, which was 100% funded by the federal government, has more than half of its sales in the U.S.
  • Johnson & Johnson's one-shot vaccine hasn't sold nearly as much due to safety concerns, but the company still expects $2.5 billion of global sales this year based on its advanced purchasing agreements.
  • The FDA still hasn't authorized AstraZeneca's shot for use in the U.S. The company hopes it will before the end of the year. AstraZeneca has been selling its shot at a not-for-profit price.

Go deeper

Updated 6 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Vaccines: CDC says some immunocompromised people can get fourth COVID shot — FDA panel endorses Pfizer vaccines for 5-11 year olds — Moderna says vaccine shows strong immune response in kids
  2. Health: 96% of Tyson Foods employees vaccinated ahead of mandate deadline — U.S. releases updated vaccination, testing rules for foreign travelers — Those who miss work without pay due to COVID also had food insecurity
  3. Politics: Alabama governor orders state agencies to fight federal vaccine mandate — Axios-Ipsos poll: Confidence in Biden COVID recovery tumbles — New York City police union files lawsuit against vaccine mandate.
  4. Education: Benefits of vaccine for children outweigh risks, FDA says — Education secretary reveals limits to Biden’s mask push on states — LA extends deadline for school employee vaccinations.
  5. Variant tracker: Where different strains are spreading.
Oct 25, 2021 - Health

DeSantis touts bonuses for unvaccinated police who relocate to Florida

Florida Gov. Ron DeSantis speaks during a press conference Friday in Kissimmee, Fla. Photo: Paul Hennessy/SOPA Images/LightRocket via Getty Images

Gov. Ron DeSantis announced plans Sunday to "hopefully sign" legislation to provide a $5,000 bonus to police officers who relocate to Florida in order to avoid COVID-19 vaccine mandates.

Why it matters: The governor's pledge during an appearance on Fox News comes amid escalating tensions with the Biden administration over its upcoming vaccine requirement for federal workers.

Oct 26, 2021 - Health

New York City police union files lawsuit against vaccine mandate

Combination images of New York City Patrolman Benevolent Association President Patrick Lynch and New York City Mayor Bill de Blasio. Photo: Andrew Lichtenstein/Corbis via Getty Images/David Dee Delgado/Getty Images

New York City's biggest police union filed a lawsuit Monday against Mayor Bill de Blasio's COVID-19 vaccine requirement for all NYC public employees.

Why it matters: The mandate requires all city employees to have had at least one dose by this Friday. They must show proof of vaccination or they'll be placed on unpaid leave. The Police Benevolent Association of New York tweeted Monday that it's seeking a temporary restraining order to halt the mandate, pending the outcome of its lawsuit.